Publication: 3680

Independent validation of the PAM50-based Chemo-Endocrine Score (CES) in hormonal receptor positive HER2-positive breast cancer treated with neoadjuvant anti-HER2-based therapy
      QxMD      Google Scholar   
Citation:
Clin Cancer Res vol 27 (11) 3116-25
Year:
2021
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
Parents:
3244  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, BCRF , R01-CA229409  
Corr. Author:
Tomás Pascual 
Authors:
                                               
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-40601
Phases:
3
Keywords:
intrinsic subtype, HER2-positive, Chemo-Endocrine Score, PAM50, breast cancer, gene expression